Skip to main content
. Author manuscript; available in PMC: 2019 Nov 27.
Published in final edited form as: Nat Methods. 2019 Jan 21;16(2):151–162. doi: 10.1038/s41592-018-0302-x

Figure 5.

Figure 5

Mapping of fusion proteins and fusion sites in all GPCR structure constructs. Mapping of fusion proteins shows that BRIL and T4L have been incorporated across a wide range of positions, in contrast to rubredoxin, PSG and flavodoxin. The number of receptors that have utilised a given fusion site (include linkers) are shown within each position in greyscale. Residue positions in the loops are indexed with the GPCRdb generic residue numbering scheme34, whereas N-terminal fusion sites represent their lengths (no. residues) after truncation (Supplementary Note).